Posted in | News | Nanomaterials | Nanobusiness

Nanocrystalline Cellulose Presentation by CelluForce at BioPlastek 2012 Forum

CelluForce, a Canada-based joint venture between Domtar and FPInnovations, will deliver a presentation about its novel nano-crystalline cellulose material and its performance-enhancing capabilities at the forthcoming BioPlastek 2012 Forum.

The BioPlastek 2012 Forum will be held at the Westin Arlington Gateway located in Arlington, Virginia, from 28 to 30 March, 2012. The innovative renewable material, nano-crystalline cellulose can be obtained from trees or other types of biomass. Nano-crystalline cellulose is produced by milling and subsequent hydrolyzing of pulp materials that result in the removal of amorphous regions. This material is then isolated and concentrated to form re-dispersible, homogenous natural nanoparticles.

Nanocrystalline cellulose can be used as a superior-performance strengthening additive to resins for improving their barrier and mechanical properties. The non-toxic nanomaterial can be recycled. It can be used as a superior-performance strengthening and barrier improvement material thanks to its large surface area and high-crystallinity. With these remarkable properties, nanocrystalline cellulose can enhance the opportunities for reinforced bioplastics in barrier packaging and in structural components and recyclable interior for the automotive market.

CelluForce successfully integrated its nanocrystalline cellulose material as an additive into thermoplastics, including biopolymers such as PHA and PLA, and polyolefins such as PE and PP. These bio-based resins demonstrate enhanced strength, light resistance, abrasion resistance, toughness, durability, and permeability resistance to gases. The company has recently wrapped up construction of its demonstration plant having a production capacity of 1 t of nanocrystalline cellulose per day. The facility has started production. The company has also started trials to incorporate the nanomaterial into the production process of various products.

Source: http://bioplastek.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). Nanocrystalline Cellulose Presentation by CelluForce at BioPlastek 2012 Forum. AZoNano. Retrieved on February 28, 2024 from https://www.azonano.com/news.aspx?newsID=24056.

  • MLA

    Chai, Cameron. "Nanocrystalline Cellulose Presentation by CelluForce at BioPlastek 2012 Forum". AZoNano. 28 February 2024. <https://www.azonano.com/news.aspx?newsID=24056>.

  • Chicago

    Chai, Cameron. "Nanocrystalline Cellulose Presentation by CelluForce at BioPlastek 2012 Forum". AZoNano. https://www.azonano.com/news.aspx?newsID=24056. (accessed February 28, 2024).

  • Harvard

    Chai, Cameron. 2019. Nanocrystalline Cellulose Presentation by CelluForce at BioPlastek 2012 Forum. AZoNano, viewed 28 February 2024, https://www.azonano.com/news.aspx?newsID=24056.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.